Filings
Trends
Rankings
Learn
Home
/
Flagship Pioneering, LLC
/
Q4 2024 Filing
Flagship Pioneering, LLC
Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$334.2B
Holdings
5
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (5 positions)
#
Stock
Shares
Value
% Portfolio
Type
1
MRNA
Moderna Inc
4,632,149
$192.6B
57.63%
2
FHTX
Foghorn Therapeutics Inc
12,674,120
$59.8B
17.90%
3
SANA
Sana Biotechnology Inc
25,001,856
$40.8B
12.19%
4
—
Omega Therapeutics Inc
29,225,579
$21.8B
6.52%
5
MCRB1EUR
Seres Therapeutics Inc
23,117,045
$19.3B
5.76%